Top Stories
-
Scientists have found that many esophageal cancers turn on ancient viral DNA embedded in our genome, a finding that could lead to improvements in immunotherapy.
-
In a new study, Columbia cancer researchers have identified a potential new drug target in lung metastases of esophageal squamous cell carcinoma.
-
Columbia cancer researchers are working to increase the representation of people of color in cancer clinical trials and decrease the health equity gap, with the help of Stand Up to Cancer.
-
Reducing levels of a hormone prevented metastasis and prolonged survival in mice with pancreatic cancer, a study from Columbia has found, which could lead to new treatments for patients.
Latest News
- December 8, 2017
A CUMC-led study finds that acupuncture can reduce the joint pain caused by aromatase inhibitors, a drug taken by two-thirds of all breast cancer patients.
Topic
- November 16, 2017
Columbia University and NYP announced today that Florence Irving and her late husband, Herbert Irving, have given $700 million to the two institutions to dramatically advance research and clinical programs for the treatment of cancer.
Topic
- November 16, 2017
Discoveries made by researchers at HICCC have fundamentally altered our understanding of cancer.
- October 11, 2017
Columbia researchers have identified cells that give rise to Barrett’s esophagus, a precursor to esophageal cancer, the fastest-growing cancer in the United States.
Topic
- October 9, 2017
Riders, sponsors, volunteers, and friends joined forces for Velocity, Columbia's Ride to End Cancer, in support of the Herbert Irving Comprehensive Cancer Center.
Topic
- September 7, 2017
Cancer immunotherapy drugs only work for a minority of patients, but a generic drug now used to increase blood flow may be able to improve those odds, a study by Columbia University Medical Center researchers suggests.
Topic
- August 30, 2017
Immunotherapy expert Pawel Muranski speaks about the new CAR-T therapy for leukemia and his work to bring T cell therapies to patients with a wide range of cancers.
Topic
- August 30, 2017
Prakash Satwani, MD, leads NYP/CUIMC's program in CAR-T therapy, a new treatment that uses a patient's own T cells to attack cancer.
Topic
- July 11, 2017
Inna Kleyman, MD, shares why she joined Velocity, a new cycling event that benefits the Herbert Irving Comprehensive Cancer Center at CUMC.
Topic
- July 11, 2017
Alexander Small, MD, shares why he joined Velocity, a new cycling event that benefits the Herbert Irving Comprehensive Cancer Center at CUMC.
Topic
